We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CSPI:NASDAQCSP Inc. Analysis

Data as of 2026-06-17 - not real-time

$9.34

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

CSP Inc. is trading at $9.34, just above its 20‑day (9.31) and 50‑day (9.30) simple moving averages but still below the 200‑day SMA of $10.71, indicating a short‑term bias that is not yet confirmed by longer‑term momentum. The RSI of 52 and a bullish MACD histogram (+0.003) suggest modest upside pressure, while the recent increase in volume adds confidence to the technical signal. However, the stock’s 30‑day volatility of 46% and a beta of 1.46 point to a highly volatile profile that could amplify price swings. On the fundamentals side, revenue jumped 22% year‑over‑year to $57.96 M, yet operating margins are negative (‑5.3%) and the company posted a small loss per share (‑$0.01), leaving the PE ratio at zero. The balance sheet shows $23.1 M of cash against $2.1 M of debt, giving a comfortable liquidity cushion but the negative free cash flow (‑$2.14 M) raises concerns about cash burn. The dividend yield of 1.27% is modest and the payout ratio is only 5.8%, but the lack of earnings makes the dividend’s sustainability questionable. Overall, the stock sits in a neutral technical zone with strong revenue growth offset by profitability challenges, high volatility, and modest valuation metrics.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD crossover with positive histogram
  • Price trading just above short‑term SMAs
  • High short‑term volatility and proximity to resistance at $10.10

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Revenue growth of 22% indicating top‑line momentum
  • Strong cash position relative to debt
  • Low dividend payout ratio providing room for reinvestment

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Persistently negative operating and net margins
  • Elevated beta and volatility suggesting price instability
  • Potential upside from defense and security contracts but uncertain profitability

Key Metrics & Analysis

Financial Health

Revenue Growth21.80%
Profit Margin-0.17%
ROE-0.22%
ROA-2.48%
Debt/Equity4.61
P/B Ratio2.1
Op. Cash Flow$-4794000
Free Cash Flow$-2143750
Industry P/E37.2

Technical Analysis

TrendNeutral
RSI51.9
Support$7.94
Resistance$10.10
MA 20$9.31
MA 50$9.30
MA 200$10.71
MACDBullish
VolumeIncreasing
Fear & Greed Index92.13

Valuation

GradeFair
TypeBlend
Dividend Yield1.27%

Risk Assessment

Beta1.46
Volatility46.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.